52 related articles for article (PubMed ID: 35284136)
1. Survival benefit of combined immunotherapy and chemoradiotherapy in locally advanced unresectable esophageal cancer: an analysis based on the SEER database.
Xie L; Zhang Z
Front Immunol; 2024; 15():1334992. PubMed ID: 38292873
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of Adjuvant Chemoradiotherapy in Early-Stage Gallbladder Adenocarcinoma Depends on the Tumor Invasion Depth and Differentiation Level.
Liang H; Wang Y; Chen J; Xing J; Pu Y
Front Oncol; 2020; 10():616170. PubMed ID: 33392099
[TBL] [Abstract][Full Text] [Related]
3. Clinical evidence for association of neoadjuvant chemotherapy or chemoradiotherapy with efficacy and safety in patients with resectable esophageal carcinoma (NewEC study).
Zhou HY; Zheng SP; Li AL; Gao QL; Ou QY; Chen YJ; Wu ST; Lin DG; Liu SB; Huang LY; Li FS; Zhu HY; Qiao GB; Lanuti M; Yao HR; Yu YF
EClinicalMedicine; 2020 Jul; 24():100422. PubMed ID: 32637899
[TBL] [Abstract][Full Text] [Related]
4. The exploration of surgery and survival prediction in patients with peritoneal metastasis from gastric adenocarcinoma based on the SEER database.
Shen Y; Yu S; Zhang Y; Wang S; Chen J; Xu Y; Hu X; Li J; Jiang S; Wang L; Xu L; Zhou Z; Deng J; Chen B; Xu X
J Gastrointest Oncol; 2024 Apr; 15(2):597-611. PubMed ID: 38756631
[TBL] [Abstract][Full Text] [Related]
5. Patterns and Trends in Adjuvant Therapy for Major Salivary Gland Cancer.
Patel AM; Haleem A; Choudhry HS; Povolotskiy R; Roden DF
Otolaryngol Head Neck Surg; 2024 Mar; ():. PubMed ID: 38482915
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness of Gastrectomy With Chemoradiotherapy Among Stage IV Gastric Adenocarcinoma: A Population-Based Analysis.
Li S; Zang L
Front Oncol; 2020; 10():630. PubMed ID: 32411605
[No Abstract] [Full Text] [Related]
7. Differential clinical outcomes after 3 versus 5 years in a comparison of preoperative chemotherapy with and without radiotherapy in locally advanced rectal cancer: A national cohort propensity score-matched study.
Zhang Y; Luo R; Peng J; He Z; Tan D; Liu X; Wang H; Wang H
Heliyon; 2024 Mar; 10(6):e27684. PubMed ID: 38524592
[TBL] [Abstract][Full Text] [Related]
8. Total neoadjuvant therapy in oesophageal and gastro-oesophageal junctional adenocarcinoma.
Clements HA; Underwood TJ; Petty RD
Br J Cancer; 2024 Jan; 130(1):9-18. PubMed ID: 37898721
[TBL] [Abstract][Full Text] [Related]
9. Multimodal treatments for resectable esophagogastric junction cancer: A Bayesian network meta-analysis.
Shao P; Nima S; Tse Y; Suolang Z; Pubu C
Langenbecks Arch Surg; 2023 Mar; 408(1):123. PubMed ID: 36934163
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery for patients with locally advanced rectal cancer: a systematic review and meta-analysis.
Feng S; Yan P; Zhang Q; Li Z; Li C; Geng Y; Wang L; Zhao X; Yang Z; Cai H; Wang X
Int J Colorectal Dis; 2020 Aug; 35(8):1355-1369. PubMed ID: 32488419
[TBL] [Abstract][Full Text] [Related]
11. Neoadjuvant Chemoradiotherapy for Locally Advanced Gastric Cancer: Where Are We at?
Yeh JH; Yeh YS; Tsai HL; Huang CW; Chang TK; Su WC; Wang JY
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740693
[TBL] [Abstract][Full Text] [Related]
12. Survival outcomes of neoadjuvant and adjuvant chemoradiotherapy for locally advanced adenocarcinoma of the oesophagogastric junction: a retrospective cohort study using the SEER database.
Zhang F; Feng X; Li Y; Yan J; Zhang Z; Song X
J Gastrointest Oncol; 2022 Feb; 13(1):26-39. PubMed ID: 35284136
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis.
Li J; Zhao Q; Ge X; Song Y; Tian Y; Wang S; Liu M; Qiao X
BMC Surg; 2021 Mar; 21(1):137. PubMed ID: 33731072
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
[No Abstract] [Full Text] [Related]
15. Clinical outcomes for hilar and extrahepatic cholangiocarcinoma with adjuvant, definitive, or liver transplant-based neoadjuvant chemoradiotherapy strategies: a single-center experience.
Laughlin BS; Petersen MM; Yu NY; Anderson JD; Rule WG; Borad MJ; Aqel BA; Sonbol MB; Mathur AK; Moss AA; Bekaii-Saab TS; Ahn DH; DeWees TA; Sio TT; Ashman JB
J Gastrointest Oncol; 2022 Feb; 13(1):288-297. PubMed ID: 35284111
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
